Synaptive Medical news

Planning brain surgery is a delicate process that requires precision to avoid damaging surrounding brain tissue and to prevent post-surgery complications. Synaptive Medical, a leader in medical technology, is set to enhance this process by evaluating its new software called Modus Plan, at Unity Health Toronto’s St. Michael’s Hospital, with support from OBIO’s Life Sciences Critical Technologies & Commercialization (LSCTC) Centre of Excellence.

M

Listen to Synaptive’s President and Co-Founder, Cameron Piron on the Epicor weekly episode of Manufacturing the Future with Kerrie Jordan.

Cameron shares invaluable leadership and entrepre

A new cohort study published in World Neurosurgery by the Neurosurgery Department at Medical University of South Carolina (MUSC) examined the use of the Synaptive Modus exoscope (n=123) versus a microscope (n=123) in spine surgery.

The use of the exoscope resulted in shorter operative time, reduced blood loss, shorter length of stay and favorable clinical outcomes compared to the use of the operative microscope:

• 19% reduction in operative time (83 mins vs 132 mins; p=0.

January’s Journal of Neurosurgery (JNS) published a series of 17 videos that examine the application of exoscopic visualization in cerebrovascular, neuro-oncologic, pediatric, peripheral nerve, and spinal neurosurgery. The video series highlights the exoscope as a versatile alternative to traditional optical microcopy.

Seven of the videos highlight the use of Synaptive’s robotic exoscope, Modus X. Surgeons from Johns Hopkins conclude that “The exoscope offers a large

Synaptive Medical, a global medical device and technology company solving surgical, imaging and data challenges, is pleased to announce the appointment of Timothy J. Scannell as the new Chair of the Board of Directors, effective June 20, 2023.

Mr. Scannell joined Synaptive Medical’s Board of Directors in August 2022, bringing a wealth of experience and expertise in the medical device industry. Prior to joining the Board at Synaptive, Mr. Scannell served as President and Chief Op

Synaptive Medical has received $900,000 in support from the Ontario government through the Ontario Together Fund. This funding will support Synaptive Medical’s $2.8 million project to expand manufacturing and research and development activities related to the company’s head-only Magnetic Resonance Imaging (MRI) system. The Synaptive MRI is a 0.5T system that was designed to overcome challenges such as accessibility in critical and acute cases like brain tumour and stroke, enabling

Fidelis Sustainability Distribution, a veteran-owned company, has been awarded a Medical Equipment ECAT contract by the Defense Logistics Agency valued at $45,000,000 USD over 5 years. The ECAT contract is an online source (electronic catalog) for Robotic Assisted Surgery and other OR related products and acts as one of the preferred purchasing sources for the Department of Defense (DoD) and the Veterans Affairs (VA) healthcare system. Fidelis Sustainability Distribution works in conjunction

Synaptive Medical, a leader in automation and robotics, announced today it has completed a sale of preferred equity totaling $17,000,000 USD. The investment was made by Sensegain Group, a leading asset management firm in China. Ms. Jing Yang, Board Member & Senior Partner of Sensegain, will join Synaptive’s Board of Directors.

Sensegain Group is headquartered in Beijing with multiple locations globally and has developed a strong partnership with industry leaders, as well as

Synaptive Medical, a leader in robotic surgical visualization, announced today the company has secured clearance from the Food and Drug Administration (FDA) for its superconducting, head magnetic resonance imaging (MRI) technology, Evry™. Synaptive developed Evry to provide medical professionals with diagnostic imaging capabilities directly at the point of care in critical care settings, which was unachievable until r